Work

Phase I evaluation of thrice-daily intravenous bolus interleukin-4 in patients with refractory malignancy.

Year: 1992

Type: article

Study design: Clinical Trial

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.1992.10.11.1802

Authors: M B Atkins, G Vachino, H J Tilg, D D Karp, N J Robert, K Kappler, J W Mier

Institution: Tufts Medical Center

Language: English

Topic: Immunotoxicology and immune responses

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Institutes of Health, National Cancer Institute, National Center for Research Resources

Awards: GENERAL CLINICAL RESEARCH CENTER, G4173429266, IMMUNOBIOLOGY OF LAK CELLS, G5963656535

OpenAlex ID: W1836425824

FWCI: 3.097

Cites: 35

Cited by: 92

Related to: 10